市场调查报告书
商品编码
1218827
全球EEG市场:到2028年的预测-按产品(频道),类型(影像,动态,常规),模式,应用,最终用户和地理分析Electroencephalography Systems Market Forecasts to 2028 - Global Analysis By Product (Multichannel, 40-channel, 32-channel, 25-channel, 21-channel & 8-channel), Type (Video, Dynamic & Conventional), Modality, Application, End User & By Geography |
根据 Stratistics MRC,全球 EEG 市场将在 2022 年占 7.7951 亿美元,到 2028 年达到 11.6329 亿美元,预测期内復合年增长率为 6.9%。
脑电图设备用于监测大脑中的电信号。 然而,这些电信号非常微弱,因此需要使用放大器来增加电压。该设备的读数用于诊断各种神经系统疾病、睡眠障碍和监测麻醉下的患者。 该设备借助戴在患者头皮上的电极收集脑电波读数。 该设备主要用于医院、诊断实验室、门诊手术中心等。
据 EMSP 称,据说欧洲约有 900 万人患有神经退行性疾□□病。 根据阿尔茨海默氏症协会的数据,大约有 650 万 65 岁以上的美国人患有阿尔茨海默氏病。 此外,73%是75岁以上的老年人。
市场动态
促进因素
神经血管疾病患病率上升
癫痫、阿尔茨海默病、痴呆、帕金森病和多发性硬化症等神经系统疾病发病率的增加是市场增长的主要原因。 预计发达国家和发展中国家公众对神经系统疾病和紊乱的认识将推动市场增长。 此外,增加政府对神经科学相关研发活动的资助也有望带来有利可图的增长。
抑制因素
低空间分辨率和无意义的结果
虽然 EEG 提供高时间分辨率,但空间分辨率很差。 即使是高时间分辨率的数据也可能不精确,因此被认为意义不大。 虽然其他技术可以显示大脑活动区域,但 EEG 需要强大的解释来总结和假设特定反应的活动区域。 然而,替代品的存在阻碍了市场的增长。
机会
老龄化社会比例增加
人口老龄化正在推动神经科学领域研发活动的增长。 由于设备技术的进步,越来越多地采用脑电图设备在手术室也是市场增长的一个因素。
威胁
设备成本高
设置传统 EEG 设备的成本高昂,并且缺乏熟练的专业人员来准确管理和操作设备,预计将阻碍预测期内的市场增长。 缺乏脑电图保险报销也被认为是一个市场挑战。
COVID-19 的影响
COVID-19 的爆发扰乱了医疗保健行业,导致对远程监控和患者参与解决方案的需求激增。 一些医疗保健机构似乎正在将患者监测推向家庭护理环境。 大流行进一步增加了对呼吸机的需求,例如用于建立 ICU 的呼吸器。 预计研究人员将评估机械通气抢救疗法对大脑的影响,以选择针对冠状病毒患者的治疗方法。
独立设备部分预计在预测期内最大
独立设备部分预计将实现有利可图的增长,因为它是最常用的 EEG 类型。 这些系统固定或嵌入在特定位置。 此类系统主要用于医院,由硬件和软件解决方案组成,使医生能够有效地解释结果。 这些设备用于记录大脑中的电活动。 这极大地促进了在此类环境中使用的独立设备的激增。
预计在预测期内,医院行业的复合年增长率最高。
由于遭受创伤性脑损伤、癫痫和其他神经系统疾病的患者数量不断增加,预计在预测期内,医院行业的复合年增长率最高。 医院是该设备的主要最终用户,因为他们需要为临床和研究目的记录节律和电活动,并详细评估结果。 因此,由于患者流失率高和再入院率高,该细分市场占据了市场主导地位。
市场份额最高的地区
由于医疗保健成本上升和包括癫痫在内的各种神经系统疾病患病率上升,预计亚太地区在预测期内将占据最大的市场份额。 此外,随着一些亚洲国家医疗基础设施的迅速发展和消费者信心的提高,对先进脑电图设备的需求预计将增长。 此外,新兴国家对医疗保健基础设施发展的日益重视也推动了该地区的增长。
复合年增长率最高的地区
由于神经系统疾病发病率增加和睡眠障碍患病率上升,预计北美在预测期内的复合年增长率最高。 先进的医疗保健基础设施的存在、患者及其家人对早期诊断的高度认识以及高技能神经科医生的存在有助于该地区的份额。
主要发展
2021年8月,美国领先的医疗器械解决方案公司Natus Medical宣布Natus新推出的XactTrode系列铂金硬膜下电极用于癫痫手术监测的首次临床试验宣布完成成功案例
2021 年 2 月,Cadwell 宣布从 Ambu A/S 收购 Sleepmate 睡眠诊断传感器。 30 多年来,Sleepmate 产品一直提供高质量、可靠的睡眠诊断传感器解决方案,此次收购将 Sleepmate 的产品组合纳入 Cadwell 用于实验室和家庭测试的睡眠诊断解决方案。
2019 年 10 月,美国精密医疗产品和服务的全球领导者 Nihon Kohden 宣布了一款无线脑电图仪 (EEG),主要用于快速评估无意识患者的脑电图资讯。我们开始销售耳机 VitalEEG .
本报告的内容
免费定制服务
订阅此报告的客户将免费获得以下自定义选项之一
According to Stratistics MRC, the Global Electroencephalography Systems Market is accounted for $779.51 million in 2022 and is expected to reach $1163.29 million by 2028 growing at a CAGR of 6.9% during the forecast period. Electroencephalography equipment is used to monitor the electrical signals of the brain. However, these electrical signals are very weak and thus, an amplifier is employed to magnify the voltage. The readings from device are used to diagnose various neurological disorders and monitor sleep disorders and patients under anaesthesia. The equipment works with the help of electrodes that are attached to the scalp of the patient to collect the reading of the brain wave. This equipment is mostly used in hospitals, diagnostic laboratories, ambulatory surgery centers, and others.
According to EMSP, approximately 9 million people in Europe are affected by neurodegenerative diseases. According to the data from the Alzheimer's Association, almost 6.5 million Americans aged 65 years and older are suffering from Alzheimer's. Seventy-three percent are of age 75 or older.
Market Dynamics:
Driver:
Rising prevalence of neurovascular disorders
Rising incidences of neurological diseases like epilepsy, Alzheimer's, dementia, Parkinson's diseases, multiple sclerosis is the primary reason for the growth of the market. The growing awareness among people about neurological diseases and disorders in developed and developing regions is expected to impel the market growth. Additionally, increased government funding for neuroscience-related R&D activities is anticipated to have lucrative growth.
Restraint:
Low spatial resolution and less meaningful results
While EEG offers a high temporal resolution, they deliver subpar results for spatial resolution. Even the data produced through the temporal resolution is inaccurate oftentimes and as such, can be considered less meaningful. Other techniques are able to display the active regions of the brain, while EEG necessitates the need for intense interpretation that would conclude and hypothesize the active regions for a specific response. However, presence of substitute products hinders the growth of the market.
Opportunity:
Increasing proportion of the aging population
Growing geriatric population has resulted in the growth of research and development activities in the neuroscience sector. In addition, technological advancements in the field of equipment increase in adoption of EEG equipment in surgery centers are the factors that contribute to the growth of the market.
Threat:
High cost associated with the equipment
The high cost associated with the setup of conventional EEG device, and the lack of skilled professionals to administer and operate the device in an accurate manner is expected to hinder the growth of the Market over the forecast period. Also, lack of reimbursement of electroencephalography procedures is projected to challenge the market.
COVID-19 Impact
The COVID-19 outbreak disrupted the healthcare industry with the demand for remote monitoring and patient engagement solutions soaring exponentially. Several healthcare facilities are likely to fuel their patient monitoring towards home care settings. The pandemic furthered the demand for ventilators, such as respiratory devices to set up ICUs. Researchers are projected to assess the effects of rescue therapies with ventilation on the brain to help select therapies for corona virus patients.
The standalone devices segment is expected to be the largest during the forecast period
The standalone devices segment is estimated to have a lucrative growth, due to it is the most commonly used type of EEGs. These systems are fixed or implanted at a particular place. Such systems are used mainly in hospital settings and consist of hardware and software solutions that allow physicians to interpret results efficiently. These devices are used to record electrical activities in the brain. This has largely contributed to the surge of standalone devices that are used in such settings.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the growing number of patients suffering from traumatic brain injuries, epilepsy, and other neurological disorders. Hospitals are primary end users of the devices because of their need to record the rhythm and electrical activity and evaluate the results in detail for clinical and research purposes. Thus, this segment dominated the market owing to the high patient turnaround and frequent readmissions.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to rise in healthcare expenditure, and surge in prevalence of various neurological disorders such as epilepsy and others. Moreover, rapidly developing healthcare infrastructure along with the rise in spending power in certain Asian countries is expected to support the demand for advanced EEG equipment. In addition, increasing focus on the development of healthcare infrastructure in developing countries propels the region growth.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, owing to increasing incidences of neurological disorders, and the rising prevalence of sleep disorders. The presence of sophisticated healthcare infrastructure, high awareness levels amongst patients and their families regarding early diagnosis, and availability of highly skilled neuro physicians are some factors attributing to its large share.
Key players in the market
Some of the key players profiled in the Electroencephalography Systems Market include Medtronic Plc, Koninklijke Philips NV, Natus Medical Inc., Cadwell Industries Inc., Electrical Geodesics, Inc., BrainScope Co. Inc., Compumedics Ltd., NeuroWave Systems Inc., Advanced Brain Monitoring Inc., Micromed SPA, Elekta AB, Nihon Kohden America, Inc., Magstim EGI, Compumedics Ltd. and Noraxon U.S.A., Inc.
Key Developments:
In August 2021, Natus Medical, a leading provider of medical device solutions in the U.S, announced the completion of the first successfully performed clinical trial by using Natus' newly launched XactTrode family of platinum subdural electrodes which will be used for Epilepsy Surgical Monitoring.
In February 2021, Cadwell announced that it acquired the Sleepmate Sleep Diagnostic Sensors from Ambu A/S. Sleepmate products provide high-quality and reliable sleep diagnostic sensor solutions for more than 30 years and this acquisition will include the Sleepmate portfolio into Cadwell's sleep diagnostic solutions for both in-lab and at-home testing.
In October 2019, Nihon Kohden, a global leader in precision medical products and services in the U.S, launched VitalEEG wireless electroencephalogram (EEG) headset which was mainly designed for quick assessment of brain-wave information in case of unconscious patients.
Products Covered:
Types Covered:
Modality Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.